AGO2は,ミトコンドリア遺伝子翻訳を活性化することによって,糖尿病性心筋病から保護する
Jiabing Zhan1,2,3, Kunying Jin1, Rong Xie1
1Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (J.Z., K.J., R.X., J.F., Y.T., C.C., H.L., D.W.W.).
Circulation
|December 21, 2023
まとめ
糖尿病性心筋病はミトコンドリアのAGO2 (アルゴナウト2) 機能障害に関連しています. ミトコンドリアAGO2の回復は,SIRT3-AGO2-CYTB軸の活性化によって心臓の機能を改善し,新しい治療標的を提供します.
科学分野:
- 心血管研究
- ミトコンドリア生物学
- 分子医学
背景:
- 糖尿病は心臓血管合併症,特に糖尿病性心筋病のリスクを大幅に増加させる.
- マイクロRNAは,サブセルラー臓器細胞に転移し,標的遺伝子を改変することによって,糖尿病性心筋病に役割を果たします.
- アルゴナウト2 (AGO2) の細胞下部内の正確な機能は,特に糖尿病の文脈では,ほとんど不明である.
研究 の 目的:
- 糖尿病と糖尿病性心筋病のマウスモデルにおける細胞内局在のAGO2の役割とメカニズムを調査する.
- AGO2が糖尿病患者の心臓機能と細胞プロセスにどのように影響するか解明する.
主な方法:
- マウスのAGO2投与に利用された再結合アデノ関連ウイルスのタイプ9.
- 心臓の構造と機能の評価は,エコーカルディオグラフィーとカテーテルマノメーターを用いて行いました.
- 分子生物学の技術を用いてタンパク質の改変と相互作用を調査した.
主要な成果:
- ミトコンドリアのAGO2レベルは糖尿病の心筋細胞で低下した.
- ミトコンドリアAGO2の過剰発現は,糖尿病による心臓機能不全を改善した.
- AGO2は,電子輸送鎖変換を活性化し,反応性酸素種を減少させ,TUFMを募集することが判明しました.
- SIRT3によって調節されるAGO2のマロニル化により,糖尿病性心筋病におけるミトコンドリアインポートが低下した.
結論:
- SIRT3-AGO2-CYTB軸は,グルコ毒性を心臓の電子輸送鎖の不均衡と結びつける.
- これらの発見は 糖尿病性心筋病に対する 新しい仕組みの洞察をもたらします
- この研究は,糖尿病性心筋病に対するミトコンドリアを標的とした治療法の開発のための基礎を築きます.
関連する概念動画
01:46Electron Transport Chain: Complex I and II
13.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.7K
01:37Mitochondria
13.0K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.0K
01:48ATP Synthase: Mechanism
14.6K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.6K
01:25cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K